NasdaqGM - Delayed Quote USD

biote Corp. (BTMD)

5.58 -0.01 (-0.18%)
At close: April 25 at 4:00 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Marc D. Beer Executive Chairman 470.18k -- 1965
Ms. Teresa S. Weber CEO & Director 1.06M -- 1953
Ms. Mary Elizabeth Conlon VP of Business Development, General Counsel & Corporate Secretary 552.36k -- 1981
Ms. Mary J. Puncochar Head of Strategic Sales & Business Analytics 465.47k -- 1964
Mr. Robert C. Peterson Chief Financial Officer -- -- 1977
Mr. Joe Butler Chief Information Officer -- -- 1962
Mr. James Elliott Gibbs II Chief People Officer -- -- --
Mr. Richard Kevin Key Chief Digital Officer -- -- 1971
Mr. Jade Beutler Head of Nutraceuticals -- -- 1963
Dr. Ross W. McQuivey M.D. Chief Medical Officer & Member of Medical Advisory Board -- -- 1972

biote Corp.

1875 W. Walnut Hill Ln #100
Irving, TX 75038
United States
844 604 1246 https://biote.com
Sector: 
Healthcare
Full Time Employees: 
194

Description

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

Corporate Governance

biote Corp.’s ISS Governance QualityScore as of April 1, 2024 is 10. The pillar scores are Audit: 10; Board: 9; Shareholder Rights: 6; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Related Tickers